ArticleCurrent issues in molecular biology2023

Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer.

Myeongjin Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.